TandemAI is an advanced technology company dedicated to reinventing drug discovery infrastructure. The company integrates proprietary AI-driven and physics-based high-performance computation with its efficient, large-scale in-house wet lab operations to deliver a turnkey drug discovery solution. Learn more at www.tandemai.com.
Location: United States
Total raised: $82M
Investors 3
| Date | Name | Website |
| - | F-Prime Ca... | fprimecapi... |
| - | OrbiMed | orbimed.co... |
| 17.01.2024 | Qiming Ven... | qimingvc.c... |
Funding Rounds 3
| Date | Series | Amount | Investors |
| 14.11.2025 | - | $22M | VCapital |
| 03.03.2023 | Series A | $35M | - |
| 23.12.2021 | Seed | $25M | - |
Persons 19
| Date | First Name | Last Name | Title | Location | |||
| - | Changhe | Qi | Vice Presi... | linkedin.c... | - | c********i... | - |
| - | Fen | Pei | Machine Le... | linkedin.c... | - | f*****i@ta... | - |
| - | Huilin | Li | Vice Presi... | linkedin.c... | - | h*******i@... | - |
| - | Ben | ElDarragi | Senior Sof... | linkedin.c... | - | b*********... | - |
| - | Arjun | Ramesh | Senior Sof... | linkedin.c... | - | a*********... | - |
| - | Bryan | Braswell | Office Ope... | linkedin.c... | - | b*********... | - |
| - | Frederick | Parsons | Associate ... | linkedin.c... | - | F*********... | - |
| - | Jinglin | Huang, PhD | Chief of S... | linkedin.c... | - | j*********... | - |
| - | Steve | Swann | Chief Scie... | linkedin.c... | - | s*********... | - |
| - | John | Geanacopou... | Director, ... | linkedin.c... | - | j*********... | - |
Show more
Mentions in press and media 15
| Date | Title | Description |
| 16.11.2025 | TandemAI Secures $22M to Propel AI Drug Discovery Innovation | TandemAI secured a $22 million Series A extension, boosting total funding past $80 million. This capital fuels advanced AI model development, computational physics integration, and extensive wet lab expansion. The company combines generativ... |
| 14.11.2025 | TandemAI Closes $22M Series A Extension Round | TandemAI, a NYC-based drug discovery company, raised $22M in Series A extension funding. Backers included KHK Fund, and V-Capital, among others. Since its founding in October 2021, the company has raised over $80M. The company intends to us... |
| 14.11.2025 | TandemAI: $22 Million Series A Extension Raised To Accelerate AI-Driven Drug Discovery | TandemAI has closed a $22 million Series A extension that will enable the company to advance its AI-driven drug discovery platform and expand its ability to serve a growing global client base. The financing includes participation from both ... |
| 23.10.2023 | TandemAI Raises $35 million | TandemAI, a technology company focused on transforming drug discovery infrastructure, announced it has raised $35 million in a Series A financing to expand its drug discovery service platform that integrates breakthrough computational tools... |
| 03.03.2023 | TandemAI Raises $35 Million in Series A Financing Led by Qiming Venture Partners | - |
| 03.03.2023 | Daily AI Roundup: Biggest Machine Learning, Robotic And Automation Updates 3rd March 2023 | This is our AI Daily Roundup . We are covering the top updates from around the world. The updates will feature state-of-the-art capabilities in artificial intelligence (AI), Machine Learning, Robotic Process Automation, Fintech, and human-s... |
| 02.03.2023 | TandemAI Raises $35 million | TandemAI, a technology company focused on transforming drug discovery infrastructure, announced it has raised $35 million in a Series A financing to expand its drug discovery service platform that integrates breakthrough computational tools... |
| 02.03.2023 | TandemAI Raises $35 Million in Series A Financing to Expand Integrated Computational and Wet Lab Solutions to Accelerate Drug Discovery | TandemAI, a technology company focused on transforming drug discovery infrastructure, announced it has raised $35 million in a Series A financing to expand its drug discovery service platform that integrates breakthrough computational tools... |
| 01.03.2023 | TandemAI Raises $35M in Series A Financing | TandemAI, a Suzhou, and Shanghai, China- and New York-based technology company focused on transforming drug discovery infrastructure, raised $35M in Series A funding. The round was led by Qiming Venture Partners with participation from Orbi... |
| 01.03.2023 | TandemAI Raises $35 Million in Series A Financing to Expand Integrated Computational and Wet Lab Solutions to Accelerate Drug Discovery | - |
Show more